The chloroplastic NADP malate dehydrogenase is completely inactive in its oxidized form and is activated by thiol/disulfide interchange with reduced thioredoxin. To elucidate the molecular mechanism underlying the absence of activity of the oxidized enzyme, we used site-directed mutagenesis to delete or substitute the two most C-terminal residues (C-terminal Val, penultimate Glu, both bearing negative charges). We also combined these mutations with the elimination of one or both of the possible regulatory N-terminal disulfides by mutating the corresponding cysteines. Proteins mutated at the C-terminal residues had no activity in the oxidized form but were partially inhibited when pretreated with the histidine-specific reagent diethyl pyrocarbonate before activation, showing that the active site was partially accessible. Proteins missing both N-terminal regulatory disulfides reached almost full activity without activation upon elimination of the negative charge of the penultimate Glu. These results strongly support a model where the C-terminal extension is docked into the active site through a negatively charged residue, acting as an internal inhibitor. They show also that the reduction of both N-terminal bridges is necessary to release the C-terminal extension from the active site. This is the first report for a thiol-activated enzyme of a regulatory mechanism resembling the well known intrasteric inhibition of protein kinases.
The chloroplastic NADP-dependent malate dehydrogenase (NADP MDH) 1 (1) (EC 1.1.1.82) catalyzes the reduction of oxaloacetate into malate. In C4-type plants, such as sorghum or maize, it belongs to the photosynthetic CO 2 fixation pathway, allowing the export of the reducing power from the mesophyll to the bundle sheath chloroplasts (1) . Among all the malate dehydrogenases, the NADP-dependent isoform exhibits a unique property: although NAD-dependent MDHs are permanently active, the NADP-dependent MDH is totally inactive in the oxidized form and activated through the ferredoxin/thioredoxin system by reduction of specific regulatory disulfides (2, 3) .
The disulfide bridges reduced by thioredoxin have been identified. The oxidized enzyme has two disulfide bonds per monomer: an N-terminal bond (cysteines 24 and 29) and a C-terminal bond (cysteines 365 and 377) (4, 5) . They are located in sequence extensions characteristic of the NADP-dependent isoform (6) . When the corresponding four cysteines were mutated, the mutant protein was permanently active (5, 7, 8) . Kinetic experiments and derivatization of the active-site histidine with diethyl pyrocarbonate (DEPC) (9, 10) demonstrated that the two regulatory disulfides played different functional roles. The C-terminal bridge is responsible for blocking the access of OAA to the active site. The reduction of the N-terminal disulfide triggers a slow conformational change at the active site that constitutes the rate-limiting step of the activation kinetics. Additional studies suggested that the conformational change is mediated by disulfide isomerization in which the reduction of the Cys 24 -Cys 29 bridge is followed by the formation of a disulfide bridge between Cys 24 and Cys 207 , located close to the active site. The newly created disulfide would then be reduced by thioredoxin, leading to a fully active enzyme when the C-terminal bridge is reduced (11) .
Little is known about the mechanism by which the C-terminal disulfide shields access to the active site. Mutation of the two C-terminal cysteines of sorghum enzyme produced a protein that exhibited low but significant activity in the absence of reductant (5) , showing that the opening of the disulfide allowed OAA to reach the active site. A deletion of the seven-most C-terminal residues of the pea enzyme by a hydrolytic cleavage with carboxypeptidase also led to an enzyme exhibiting some spontaneous activity (i.e. activity without reduction), although the C-terminal bridge was still present (12) . This suggested that the C-terminal extension might be involved in the locking of the active site independently of the disulfide. A tentative interpretation of these observations was proposed on the basis of structural modeling (13) ; it was predicted that the side-chain carboxyl of Glu 388 and terminal carboxyl of Val 389 would mimic OAA and interact with positively charged side chains of activesite arginines. The opening of the C-terminal bridge would lead to a displacement of the extension, thus unlocking the active site. In the present study, we investigated a possible role for the two C-terminal residues in the shielding of the active site by using site-directed mutagenesis either to delete the last two C-terminal residues or to eliminate the negative charge of the penultimate residue. The results support a docking model where the negatively charged C-terminal residues bind to positively charged residues of the active-site pocket. In addition, they show an interaction between the C-terminal and the Nterminal ends of the enzyme, with the release of the C-terminal extension being dependent on the conformational change triggered by the reduction of the N-terminal bridges.
EXPERIMENTAL PROCEDURES
Materials-Restriction endonucleases, DNA modification enzymes, T4 DNA ligase, and T4 DNA polymerase were obtained from Appligene.
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¶ To whom correspondence should be addressed. DEAE-Sephacel and Matrex red A chromatographic supports were respectively from Amersham Pharmacia Biotech and Grace-Amicon. Chemicals (purchased from Sigma, Boehringer Mannheim, or Prolabo) were of analytical grade. Oligonucleotides were purchased from Eurogentec and Life Technologies, Inc. Radiolabels were from Amersham Pharmacia Biotech. Escherichia coli strain XL1 blue (CLONTECH) was used to produce high yields of plasmids and M13 single-stranded DNA. E. coli strain RZ1032 (Amersham Pharmacia Biotech) was used to produce dU-substituted M13 single-stranded DNA for site-directed mutagenesis. E. coli strain BL21 (DE3) (14) was used for the production of mutated NADP MDHs encoded by recombinant pET vectors. M13 mp19 phage (Amersham Pharmacia Biotech) was used for site-directed mutagenesis. pUC 9 (15) was used when needed for cloning strategy. pET-8c (14) was used for production of recombinant NADP MDHs. Bacteria were grown at 37°C on Luria broth medium; ampicillin at 50 g/ml was added when the bacteria carried plasmids conferring drug-resistance.
Preparation of Mutated mdh cDNAs-The cDNAs encoding the NADP MDH where the Glu 387 was replaced by a Gln (E387Q mutant protein) and the NADP MDH where the last two residues (Glu 387 and Val 388 ) were deleted (mutant ⌬(E387V388)) were obtained by site-directed mutagenesis using the method of Kunkel (16) The singlestranded M13 template used was M13mdh, a vector in which the wild-type NADP MDH cDNA is cloned (17) . The sequences of the mutagenic oligonucleotides used for the E387Q and the ⌬EV mutations are, respectively, 5Ј-CTACCGGGACAAGTGTAGTTTAG-3Ј and 5Ј-CT-ACCGGGATAGTTTAGTTAC-3Ј. A screening of the mutants was performed by sequencing single-stranded M13 DNA obtained from a few plaque isolates. A clone of each mutation was selected, and the entire cDNAs were sequenced to make sure no undesired mutations were present. The NcoI-BamHI fragment of both mutated MDH cDNAs were transferred to a pET vector for production of the modified proteins, leading to vectors pET-mdh(E387Q) and pET-mdh(⌬(E387V388)). The cDNAs containing the combined mutations C29S/C207A/E387Q and C29S/C207A/⌬(E387V388) were obtained by exchanging the NheI-NheI fragment of pET-mdh(C29S/C207A/C365A/C377A) (11) for the corresponding fragment of respectively pET-mdh(E387Q) and pETmdh(⌬EV), thus leading to vectors pET-mdh (C29S/C207A/E387Q) and pET-mdh (C29S/C207A/⌬(E387V388)). The cDNAs containing the combined mutations C29S/E387Q and C29S/⌬(E387V388) or C207A/E387Q and C207A/⌬(E387V388) were obtained by exchanging the NheI-NheI fragment of pET-mdh(C29S/C365A/C377A) or pET-mdh(C207A/C365A/ C377A) (11) for the corresponding fragment of respectively pETmdh(E387Q) and pET-mdh(⌬EV). To obtain the cDNA coding for the NADP MDH with the double mutation C29S/C207A, the NheI-NheI fragment of pET-mdh (C29S/C207A/⌬(E387V388)) was exchanged for the corresponding fragment pET-mdh(C182A). As the NheI-NheI fragment of pET-mdh(C182A) does not have any mutation, a pETmdh(C29S/C207A) was created.
DNA Sequencing-The DNA sequencing was done using the dideoxy chain termination method (18) (T7 sequencing kit, Amersham Pharmacia Biotech). For every mutated cDNA, the sequence of the whole NcoI/BamHI fragment in the expression vector was checked before recombinant protein production.
Production and Purification of Recombinant NADP MDHs-The mutated NADP MDHs were produced using the pET/BL21 production system. The experimental procedures for the production of the mutated proteins and for the preparation of soluble protein extracts from E. coli were described in Issakidis et al. (17) . The main steps consisted of ammonium sulfate fractionation, ion-exchange chromatography on DEAE-Sephacel, and affinity chromatography on Matrex Red A. When needed, a hydrophobic interaction step on TSK phenyl 5PW column was added. The NADP MDH was then dialyzed against 20 mM potassium phosphate buffer, pH 7.2, 1 mM EDTA and concentrated.
Polyacrylamide Gel Electrophoresis-Proteins were separated by vertical SDS-polyacrylamide gel electrophoresis following the method of Schä gger and Von Jagow (19) . They were visualized by Coomassie Brilliant Blue staining.
Protein Sequencing-The N-terminal sequence of the purified proteins was verified with an Applied Biosystems model 476A automated sequencer equipped with an on-line phenylthiohydantoin derivative analyzer.
Activation and Enzyme Activity Assay-Malate dehydrogenase activity of crude extracts and purified samples was assayed by measuring the decrease in absorbance at 340 nm at 30°C. The enzyme was activated at 25°C in 100 mM Tris-HCl buffer, pH 7.9, by 20 M E. coli thioredoxin (purified as in Ref. 20 ) and 10 mM DTT. NADP MDH activity was measured on aliquots in a standard assay mixture (1 ml) containing 100 mM Tris-HCl, pH 7.9, 750 M oxaloacetate, and 140 M NADPH, unless otherwise indicated.
Determination of Kinetic Parameters of Recombinant NADP MDHsThe K m values for NADPH and oxaloacetate were measured with preactivated enzymes, unless otherwise indicated by varying the concentration of one of the substrates at a saturating concentration of the other. S 0.5 for thioredoxin were determined by measuring the initial rates of NADP MDH activation in the presence of different concentrations of thioredoxin.
DEPC Treatment-The sensitivity of the various mutants to inhibition by DEPC was tested by adding the reagent at a 1 mM concentration either before or after the activation of the enzymes by reduced thioredoxin using incubation conditions described previously (9, 10) . Enzyme activity was measured on aliquots as a function of time. Protection by NADPH was performed by adding the reduced cofactor (1 mM) before DEPC treatment.
Three-dimensional Modeling and Docking Experiments-A model of the three-dimensional structure of sorghum MDH was made using the program MODELLER (21) . The coordinates of the Thermus flavus MDH (pdb ID:1bmd), the structure having the highest amino acid sequence identity (50%) to that of the sorghum enzyme, were used as a template. The N-and C-terminal extensions, characteristic for the NADP MDHs, are not present in any of the other solved MDH structures; hence these regions could not be modeled. The program 
FIG. 2. Sensitivity to DEPC of E387Q mutant NADP MDH.
The unactivated enzyme was preincubated with 1 mM DEPC for 5 min at pH 6.8. Then the pH was raised to 7.9, the activation medium (10 mM DTT ϩ 20 M thioredoxin) was added, and the activation followed by the appearance of activity as a function of time. The controls were preincubated with an equivalent volume of ethanol (final concentration: 5%). The results are expressed as the percentage of maximum activity. In these conditions, DEPC had no effect on the WT enzyme. For the protection by the cofactor experiment, 1 mM of NADPH was added before DEPC treatment. Similar results were obtained with ⌬EV mutant. Circles, E387Q MDH; squares, E387Q MDH ϩ DEPC; triangles, E387Q MDH ϩ NADPH ϩ DEPC.
AUTODOCK (22) was used to dock a dipeptide corresponding to the last two C-terminal amino acids, Glu 387 and Val 388 , into the active site of the sorghum MDH model. This program randomly maneuvers a ligand to simultaneously determine both the optimum position and conformation of a ligand bound to its macromolecule receptor. This was done through Monte-Carlo-simulated annealing with rapid energy evaluation by means of affinity grids. The grid used in the present study consisted of 120 ϫ 120 ϫ 120 points with 0.4 Å spacing between each point and was centered around the NADP in the active site. For the purposes of energy calulation, polar hydrogens were added to both the protein and the dipeptide ligand. Charges were from Wener et al. (23) , and potential parameters were as supplied by the software authors. Each MonteCarlo cycle consisted in the evaluation of 3000 configurations. 50 independent cycles were carried out, and the energetically best configuration among all of them was taken to be the final "docked" configuration. 387 and Val 388 -To evaluate the roles of the negative charges of the penultimate Glu 387 and of the C-terminal Val 388 in the lack of activity of the oxidized form of NADP-malate dehydrogenase, two mutated proteins were created by site-directed mutagenesis. In the first one, the negatively charged side chain of Glu 387 was replaced by the neutral side chain of Gln (E387Q mutant), and in the second one, the two most C-terminal residues were deleted (⌬EV mutant). After production in E. coli, both mutant proteins were purified, and their biochemical properties were analyzed. If the mutations of C-terminal negative charges were able to mimic the substitution of the Cys of the C-terminal disulfide, the mutants should exhibit the specific features of the latter, i.e. (I) WT-like, thioredoxin-dependent, activation kinetics, (II) total lack of inhibition of the activation by NADP, (III) discrete spontaneous activity (5% that of the activity of the reduced form), (IV) total inhibition by DEPC added before activation (5) . As predicted, the activation time courses of both mutant proteins were similar to that of the WT protein, and NADP did not inhibit the activation (Fig. 1) . No activation was observed with the chemical reductant DTT (data not shown). S 0.5 for thioredoxins and kinetic characteristics (K m or k cat ) of the activated enzymes were not significantly different from those of the WT enzyme (data not shown). However, the mutant enzymes did not exhibit any activity in the oxidized form, which suggested that the access to the active site was still locked. Nevertheless, DEPC partially inhibited the mutant proteins when added before activation, and NADPH protected against inhibition (Fig. 2) , indicating that DEPC targeted the active-site histidine, like in the unactivated C-terminal Cys mutants and all of the fully activated proteins (9, 10). The unactivated enzymes were preincubated with 1 mM DEPC for 5 min at pH 6.8, and their activity was followed as a function of time of contact with the reagent. The controls were preincubated with an equivalent volume of ethanol (5% final concentration). Then the pH was raised to 7.9, the activation medium (DTT ϩ thioredoxin (TRX)) was added, and the activation was followed by the appearance of activity as a function of time. Open symbols, without DEPC. Closed symbols, with DEPC. Circles, C29S/C207A/E387Q; triangles, C29S/C207A/⌬EV.
RESULTS

Study of NADP MDH Mutated at Glu
TABLE I Kinetic and activation parameters of mutant NADP-MDHs
The K m for substrates of the oxidized proteins were determined either by varying NADPH from 2.8 to 280 M at the saturating concentration (3.75 mM) of oxaloacetate or oxaloacetate from 7.5 M to 7.5 mM at the saturating concentration (140 M) of NADPH. The K m for substrates of the reduced proteins were determined on proteins fully activated by preincubation with 20 M thioredoxin and 10 mM DTT. The NADPH ranged from 2.8 to 280 M at the saturating concentration (780 M) of oxaloacetate, and oxaloacetate ranged from 7.5 M to 1.5 mM at the saturating concentration (140 M) of NADPH. The spontaneous activity rate was determined by measuring activity before and after activation by 20 M thioredoxin and 10 mM DTT; activities were measured in the presence of saturating concentrations of substrate (3.75 mM OAA for the oxidized enzymes, 780 M OAA for the reduced enzymes) in 100 mM Tris, pH 7.9. The activation process of NADP MDH being very complex, the interaction between the isomerization/reduction of the Nterminal disulfide bridges and the unshielding of the active site by the C-terminal extension has been investigated by combining mutations of the N-terminal regulatory cysteines with mutations of the C-terminal negative charges.
Study of Mutant NADP MDHs Having No N-terminal Disulfides: Mutants C29S/C207A/E387Q and C29S/C207A/⌬EV-
The first set of mutations combined the removal of the Cterminal negative charges with the total elimination of the N-terminal disulfides. In these mutants the active site should have reached its optimal catalytic conformation. The cDNAs of NADP MDH bearing the mutations C29S/C207A (a control with no N-terminal disulfide but with the C-terminal negative charges being still present), C29S/C207A/E387Q, or C29S/ C207A/⌬EV were created. The corresponding proteins were produced and purified. The C29S/C207A NADP MDH was very similar in behavior to the previously studied C24S/C29S mutant (17) ; it had no spontaneous activity, was activated much faster than the WT protein, and was strictly dependent on reduced thioredoxin for activation. In contrast, the C29S/ C207A/E387Q or C29S/C207A/⌬EV mutants (Fig. 3) exhibited a high spontaneous activity, which could be fully inhibited by DEPC (Fig. 4) . They were activated by reduced thioredoxins almost instantaneously and also by DTT alone, although at a much slower rate. A comparison of the K m values for both the oxidized and reduced enzymes (Table I ) revealed no significant differences in the apparent affinity for NADPH, whereas the K m for OAA was dramatically increased in the oxidized forms. The spontaneous activities of the oxidized forms, measured at saturating OAA concentrations, were 95% that of the activities of the corresponding reduced forms. The oxidized mutants thus appeared to differ from the reduced ones only by their lower k cat /K m ratios (Table I) .
The dramatic modifications brought about by the mutation of a single C-terminal negative charge in an MDH devoid of its N-terminal disulfides clearly show that this negative charge plays a major role in blocking the access of OAA to the active site but indicate that the N-terminal extension also plays a role in this mechanism. In a second set of experiments, the role of the reduction of each of the N-terminal disulfides in unblocking the active site has been examined separately by creating combined mutants where only one of the two possible N-terminal disulfides was eliminated.
Study of Mutant NADP MDHs Retaining One of the Two N-terminal Disulfides: Mutants C29S/E387Q, C29S/⌬EV, C207A/E387Q
, and C207A/⌬EV-The most striking difference in these mutants, compared with the mutants having no The unactivated enzymes were preincubated with 1 mM DEPC for 5 min at pH 6.8. Then the pH was raised to 7.9, the activation medium (DTT ϩ thioredoxin) was added, and the activation was followed by the appearance of activity as a function of time.
FIG. 6. Sensitivity to DEPC of NADP MDHs combining C-terminal mutations with the mutation of Cys
207 . The unactivated enzymes were preincubated with 1 mM DEPC for 5 min at pH 6.8. Then the pH was raised to 7.9, the activation medium (DTT ϩ thioredoxin) was added, and the activation was followed by the appearance of activity as a function of time. Open symbols, without DEPC (controls); closed symbols, with DEPC. Circles, C29S/⌬EV; squares, C29S/C207A/⌬EV. The C207A/⌬EV mutant exhibited a behavior very similar to the one of the C29S/⌬EV mutant. The V max ox /V max red ratios were, respectively, 4.5% (C29S/ ⌬EV), 2.1% (C207A/⌬EV), and 95% (C29S/C207A/⌬EV).
TABLE II Activation parameters of mutant NADP-MDHs
The purified preparations of the wild-type and mutant NADP-MDHs were activated by either 20 M thioredoxin and 10 mM DTT or by 10 mM DTT. The kinetics of activation were followed. The t 1/2 is the time necessary to reach 50% maximum activation. The activities were measured in the presence of saturating substrate concentrations for each enzyme, in 0.1 M Tris, pH 7.9, 30°C. For C207A and C29S mutant proteins, no activation can be detected when incubated in the presence of 10 mM DTT, 0.1 M Tris, pH 7.9. (Table I) , fast activation kinetics in the presence of reduced thioredoxin (Table II) , and ability to be activated by DTT alone at a slow rate (Table II) . The accessibility of their active sites was demonstrated by the inhibition of the unactivated enzymes by DEPC ( Fig. 5 and 6 ). In contrast, the single N-terminal mutants C29S and C207A were strictly thioredoxin-dependent (Table II) and totally insensitive to DEPC (11) . Plots of the activities of combined C-terminal mutants having either one N-terminal disulfide left or no N-terminal disulfide as a function of OAA concentration (Fig. 7) made it clear that when no N-terminal bridge is left, the oxidized enzyme is able to reach the same V max as the reduced form but only at a substantially higher OAA concentration. Thus the reduction of the C-terminal disulfide is still required for the enzyme to reach full catalytic efficiency. In contrast, when an N-terminal disulfide is still present, the oxidized enzyme cannot reach more than 4% that of the activity of the reduced form. This experiment also illustrates the fact that an activation time course, which is performed at a concentration that is saturating for the reduced enzyme, but not for the oxidized enzyme, to prevent substrate inhibition from developing during the activation process, reflects not only the increase in V max but also the decrease in K m during the conformational change of the active site into its high efficiency form.
DISCUSSION
The oxidized WT MDH is a very compact enzyme, insensitive to derivatization agents and chemical reductants, inaccessible to OAA, and exclusively reducible by thioredoxin. Previous studies showed that its structure was loosened upon activation (24, 25) and that the C-terminal disulfide was responsible for blocking access of OAA to the active site (5). The results of the present study demonstrate that the negative charge of the penultimate Glu 387 is directly involved in this blocking. In fact, all the enzymes mutated at this residue acquired some of the features of the C-terminal Cys mutants, in particular the ability to be inhibited by DEPC in the unactivated form. For all of them, a protection by NADPH was observed, indicating that the target of DEPC was the active-site His. The sensitivity to DEPC was enhanced by the additional mutation of N-terminal disulfides, which does not confer any DEPC sensitivity per se. The characteristics of the ⌬EV mutant proteins were not fundamentally different from those introduced by the mutation of the single Glu 387 , indicating that most of the effects are because of the carboxyl group of this single residue.
The sensitivity to DEPC is not paralleled by the appearance of a spontaneous activity in the single C-terminal charge mutants, showing that the access to the active site is more restricted than in the C365A/C377A mutant. Thus, even in the absence of the penultimate carboxyl, a steric hindrance remains, certainly because of the fact that the C-terminal disulfide still maintains the C-terminal extension in a conformation unfavorable for activity. Three negatively charged residues are still present in the extension (D 378 , E 381 , D 382 : Ref. 6 ) and might repel OAA. In contrast, DEPC is a hydrophobic reagent, with no negative charges and, thus, should be able to reach the active site more easily.
When the removal of the N-terminal disulfide(s) is combined with the mutation of the C-terminal negative charges, a spontaneous activity is observed in most of the oxidized enzymes. This activity is particularly high when both N-terminal disulfides are absent, a situation where the conformation of the active site is catalytically optimal. In this case, the oxidized enzymes can reach full activity but only at high OAA concentration. This result shows that the oxidized C-terminal extension impairs to some extent the access to the active site and also makes clear the cooperativity between events occurring at the N terminus and those occurring at the C terminus. Indeed, the proteins devoid of N-terminal disulfides have no spontaneous activity at all if the penultimate Glu is present. Thus it is obvious that the conformational change triggered by the reduction of the N-terminal disulfides helps release the C-terminal extension from the active site. A tentative scheme of the structural modifications brought about by the different combinations of mutations is presented in Fig. 8 .
The ability of DTT alone (in the absence of thioredoxin) to activate MDH is also an indication of loosening of the structure. The C29S, C207A, and C29S/C207A mutants as well as the E387Q or ⌬EV mutants are strictly dependent on reduced thioredoxin for activity. Combining mutations at both ends yields proteins that can be fully activated by DTT alone, although at a much slower rate. In this regard, the C29S/C207A/ E387Q mutant is particularly interesting as only one disulfide, i.e. the Cys 365 -Cys 377 disulfide, remains in this mutant. When comparing it to the strictly thioredoxin-dependent C29S/C207A mutant protein, it appears that the additional mutation of Glu 387 renders the 365-377 disulfide accessible to DTT. An increase in the activation rates by reduced thioredoxin can also be noted (Table II) , consistent with a synergistic interaction between the N-terminal extension and the C-terminal extension during the activation process.
The results of the present study support an internal inhibition model for the mechanism by which the C-terminal extension shields the access to the active site in the oxidized enzyme. Obviously the penultimate C-terminal residue is involved in the oxidative inhibition process via its negative charge. It is also clearly responsible for the NADP inhibition effect. The coenzyme binding site is accessible from the outside in NADP MDH, even in the unactivated enzyme. This suggests that the C-terminal extension can enter deep into the active site. This interpretation is supported by modeling the NADP MDH structure (Fig. 9) using the coordinates of the T. flavus NAD-MDH (26) , which shares 50% identity with the former. In particular, the overall length of the C-terminal extension is sufficient to reach the active-site residues, and the C-terminal dipeptide can be perfectly docked into the active site, mimicking the substrate OAA. However, a definite demonstration of autoinhibition of NADP MDH by its C-terminal extension would require identification of the positively charged partners of the negatively charged C-terminal residues. The experiments reported are also the first indication that during the activation process, the conformational change of the active site and its unshielding may act synergistically. Intrasteric inhibition is well documented in the case of protein kinases (27) , where an amino acid stretch in the protein sequence functions as a pseudo-substrate. Other proteins are autoinhibited through the closure of a mobile lid over the active-site pocket (28) . NADP MDH exhibits the unique feature of combining an intrasteric inhibition with a conformational change linked to disulfide isomerization. The inhibition of its activity under oxidative conditions appears to be very complex, especially because its activation is prevented by the oxidized form of the cofactor by a mechanism that is still poorly understood. 
